Long survival in Leigh Syndrome: new cases and review of literature

  • Wiebke Aulbert
  • Katharina Weigt-Usinger
  • Charlotte Thiels
  • Cornelia Köhler
  • Matthias Vorgerd
  • Anja Schreiner
  • Sabine Hoffjan
  • Tobias Rothoeft
  • Saskia Brigitte Wortmann
  • Christoph Malte Heyer
  • Teodor Podskarbi
  • Thomas Lücke

Related Research units

Abstract

Leigh syndrome (MIM 25600), also known as infantile subacute necrotizing encephalomyelopathy, is a neurodegenerative disorder with characteristic bilateral symmetric lesions in basal ganglia and subcortical brain regions. It is commonly associated with systemic cytochrome c oxidase (COX) deficiency and mutations in the SURF1 gene (MIM 185620), encoding a putative assembly or maintenance factor of COX. The clinical course is dominated by neurodevelopmental regression, brain stem, and basal ganglia involvement (e.g., dystonia, apnea) with death often occurring before the age of 10 years. Herein, we present three sisters carrying a previously reported homozygous SURF1 mutation (c.868_869insT) that is predicted to result in a truncated protein with loss of function. Our patients show heterogeneous clinical findings with different distribution patterns of metabolic lesions in brain magnetic resonance imaging (MRI) as well as a Chiari malformation with hydrocephalus in one patient. However, all three siblings show an unusual long survival (12 years and>16 years). COX activity was not detectable in one patient and strongly reduced in the other two. We discuss these findings with respect to a review of the literature. A total of 15 additional patients with survival>14 years have been reported so far. Overall, no clear genotype-phenotype correlations are detectable among these patients.

Bibliographical data

Original languageEnglish
ISSN0174-304X
DOIs
Publication statusPublished - 01.12.2014
PubMed 25111564